The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs
Authors:
- Chandra BortolottoCBChandra Bortolotto
- Gaia MessanaGMGaia Messana
- Antonio Lo TitoATAntonio Lo Tito
- Giulia Maria StellaGiulia Maria Stella
- Alessandra PintoAPAlessandra Pinto
- Chiara PodreccaChiara Podrecca
- Riccardo BellazziRBRiccardo Bellazzi
- Alessia GerbasiAGAlessia Gerbasi
- Francesco AgustoniFAFrancesco Agustoni
- Fei HanFHFei Han
- Marcel Dominik NickelMNMarcel Dominik Nickel
- Domenico ZacàDZDomenico Zacà
Open Access
Abstract
We investigated the association of T1/T2 mapping values with programmed death-ligand 1 protein (PD-L1) expression in lung cancer and their potential in distinguishing between different histological subtypes of non-small cell lung cancers (NSCLCs). Thirty-five patients diagnosed with stage III NSCLC from April 2021 to December 2022 were included. Conventional MRI sequences were acquired with a 1.5 T system. Mean T1 and T2 mapping values were computed for six manually traced ROIs on different areas of the tumor. Data were analyzed through RStudio. Correlation between T1/T2 mapping values and PD-L1 expression was studied with a Wilcoxon–Mann–Whitney test. A Kruskal–Wallis test with a post-hoc Dunn test was used to study the correlation between T1/T2 mapping values and the histological subtypes: squamocellular carcinoma (SCC), adenocarcinoma (ADK), and poorly differentiated NSCLC (PD). There was no statistically significant correlation between T1/T2 mapping values and PD-L1 expression in NSCLC. We found statistically significant differences in T1 mapping values between ADK and SCC for the periphery ROI (p-value 0.004), the core ROI (p-value 0.01), and the whole tumor ROI (p-value 0.02). No differences were found concerning the PD NSCLCs.Keywords
Funding Information
- Fondazione IRCCS Policlinico San Matteo (20190049910)
This publication has 29 references indexed in Scilit:
- T1 MappingJACC: Cardiovascular Imaging, 2016
- Longitudinal analysis of 2293 NSCLC patients: A comprehensive study from the TYROL registryLung Cancer, 2015
- Feasibility assessment of using oxygen-enhanced magnetic resonance imaging for evaluating the effect of pharmacological treatment in COPDEuropean Journal of Radiology, 2014
- Myocardial Tissue Characterization by Magnetic Resonance ImagingJournal of Thoracic Imaging, 2014
- Native T1 Mapping of the Heart – A Pictorial ReviewClinical Medicine Insights: Cardiology, 2014
- Advances in Parametric Mapping With CMR ImagingJACC: Cardiovascular Imaging, 2013
- Magnetic Resonance Imaging for Lung CancerJournal of Thoracic Imaging, 2013
- Noncontrast T1 Mapping for the Diagnosis of Cardiac AmyloidosisJACC: Cardiovascular Imaging, 2013
- Practical medical applications of quantitative MR relaxometryJournal of Magnetic Resonance Imaging, 2012
- Myocardial Edema as Detected by Pre-Contrast T1 and T2 CMR Delineates Area at Risk Associated With Acute Myocardial InfarctionJACC: Cardiovascular Imaging, 2012